Dr Agarwal's Hea
Medical Instruments & Supplies · AGARWALEYE
Mid CapHealthcareHigh Growth
Dr. Adil Agarwal
Whole-time Director and CEO · Visionary
Company DNA
Founder-Centric
About
Dr Agarwal's Hea is a Mid Cap company in the Healthcare sector, listed on NSE as AGARWALEYE. With a market cap of ₹14K Cr and revenue of ₹2K Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Startup-Speed pace. High promoter holding of 75.5% with the founding family deeply involved in operational leadership and brand identity. Its strategic mandate: Aggressive scaling of the eye-care hospital network necessitates a visionary leader to capitalize on consolidation opportunities in a fragmented healthcare market.
FAQ
What kind of company is Dr Agarwal's Hea?
Dr Agarwal's Hea is a Mid Cap Healthcare company (AGARWALEYE) in the High Growth phase with a market cap of ₹14K Cr. It is classified as Founder-Centric in culture.
What is Dr Agarwal's Hea's culture and work environment like?
Dr Agarwal's Hea has a Founder-Centric culture with Fast-Follower innovation DNA and a Startup-Speed pace of execution. Employee brand: Learning Ground. Customer relationship style: Mass-Consumer. High promoter holding of 75.5% with the founding family deeply involved in operational leadership and brand identity.
Who leads Dr Agarwal's Hea?
Dr Agarwal's Hea is led by Dr. Adil Agarwal (Whole-time Director and CEO), a Visionary leader with 17 years of experience.
What are Dr Agarwal's Hea's financials?
Dr Agarwal's Hea reported revenue of ₹2K Cr in FY25 with a 5-year revenue CAGR of 34.8%. Operating margin: 14.6%. Market cap: ₹14K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceStartup-Speed
PurposeMission-First
CustomerMass-Consumer
EmployeeLearning Ground
BrandTrusted
LifecycleHigh Growth
High promoter holding of 75.5% with the founding family deeply involved in operational leadership and brand identity.
Mandate
Aggressive scaling of the eye-care hospital network necessitates a visionary leader to capitalize on consolidation opportunities in a fragmented healthcare market.
Aggressive scaling of the eye-care hospital network necessitates a visionary leader to capitalize on consolidation opportunities in a fragmented healthcare market.
Financials
Revenue FY25₹2K Cr
PAT FY25₹83 Cr
Rev CAGR 5Y34.8%
OPM14.6%
NPM4.9%
ROE4.5%
ROCE7.8%
P/E107.6
Fwd P/E75.5
P/B7
D/E48.7
Mkt Cap₹14K Cr
Promoter75.5%
Institutional16.6%
Similar Culture
Could You Lead Dr Agarwal's Hea?
Take the Genome Benchmark →